John A. Double
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
- Clinical Biochemistry top 5%
Papers in
- Pharmacology 14
- Flavonoids in Medical Research 9
- Synthesis of Organic Compounds 5
- Pharmacogenetics and Drug Metabolism 5
- Oncology 13
- Colorectal Cancer Treatments and Studies 7
- Co-authors
- M C Bibby (37 shared papers)Roger M. Phillips (22 shared papers)Paul Workman (9 shared papers)Paul M. Loadman (18 shared papers)Ian James Stratford (4 shared papers)Lloyd R. Kèlland (3 shared papers)Angelika M. Burger (2 shared papers)Fangping Dai (1 shared paper)
- Journals
- British Journal of Cancer (25 papers)Biochemical Pharmacology (10 papers)JNCI Journal of the National Cancer Institute (5 papers)European Journal of Cancer (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- United KingdomIrelandNetherlands
In The Last Decade
John A. Double
117 papers receiving 4.6k citations
John A. Double's Hit Papers
Peers
Comparison fields: 5 of 85
- Toxicology 177
- Clinical Biochemistry 70
- Cancer Research 204
- Molecular Biology 969
- Oncology 318
Countries citing papers authored by John A. Double
This map shows the geographic impact of John A. Double's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Double with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Double more than expected).
Fields of papers citing papers by John A. Double
This network shows the impact of papers produced by John A. Double. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Double. The network helps show where John A. Double may publish in the future.
Co-authors
The 25 scholars most cited alongside John A. Double, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the welfare and use of animals in cancer research Hit paper breakdown → | 2010 | 1215 |
| 2 | 2005 | 515 | |
| 3 | 2000 | 182 | |
| 4 | 1996 | 150 | |
| 5 | 1997 | 129 | |
| 6 | 1989 | 113 | |
| 7 | 2003 | 106 | |
| 8 | Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. | 1987 | 104 |
| 9 | 1993 | 95 | |
| 10 | 1990 | 86 | |
| 11 | 1989 | 82 | |
| 12 | 2004 | 82 | |
| 13 | Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development. | 2003 | 80 |
| 14 | 1995 | 77 | |
| 15 | 1997 | 77 | |
| 16 | Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles. | 2002 | 73 |
| 17 | 2000 | 70 | |
| 18 | 1966 | 67 | |
| 19 | 1992 | 57 | |
| 20 | 1987 | 56 |
About John A. Double
John A. Double is a scholar working on Pharmacology, Oncology, Pharmacology, Toxicology and Physiology, having authored 118 papers that have together received 4.8k indexed citations. Recurring topics across this work include Flavonoids in Medical Research (9 papers), Colorectal Cancer Treatments and Studies (7 papers), Telomeres, Telomerase, and Senescence (6 papers), Synthesis of Organic Compounds (5 papers), Synthesis and biological activity (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Toxicology (177 citations), Clinical Biochemistry (70 citations), Cancer Research (204 citations), Molecular Biology (969 citations) and Oncology (318 citations). John A. Double has collaborated with scholars based in United Kingdom, Ireland and Netherlands. Frequent co-authors include M C Bibby, Roger M. Phillips, Paul Workman, Paul M. Loadman, Ian James Stratford, Lloyd R. Kèlland, Angelika M. Burger, Fangping Dai, Stephen Neidle and Anthony P. Reszka. Their work appears in journals such as British Journal of Cancer, Biochemical Pharmacology, JNCI Journal of the National Cancer Institute, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.